Skip to content
Aminoscope
← Research
Longevity

Sulforaphane: real human data, in niches that aren't longevity

The broccoli-sprout Nrf2 activator has genuine randomized trials — for autism and type-2 diabetes. But its anti-aging claims are preclinical, and bioavailability depends heavily on the preparation.

Theo Lindqvist7 min read
Sulforaphane activates Nrf2, the cell's antioxidant-defense switchsulforaphanefrom broccoli sproutsNrf2master switchantioxidantdefenses ↑ACTIVATES NRF2 · THE CELL-DEFENSE SWITCH

Sulforaphane is the molecule behind the “eat your broccoli sprouts” longevity advice — and it’s a more interesting case than most supplements, because it actually has randomized human trials. The catch is what those trials studied: not aging, but two specific conditions. Separating the real human evidence from the longevity marketing is the job here.

What it is and how it works

Sulforaphane is an isothiocyanate concentrated in broccoli sprouts. Its mechanism is well established: it’s one of the most potent natural activators of Nrf2 — the transcription factor that switches on the cell’s antioxidant and detoxification genes.[1] That Nrf2-activating, “turn up your own defenses” mechanism is the basis for every claim made about it, from cancer chemoprevention to anti-aging.

Where it has real human data

Two areas stand out, both with randomized trials. In autism, a placebo-controlled RCT in young men with moderate-to-severe ASD found 18 weeks of sulforaphane improved behavior scores substantially — about a 34% improvement on the ABC scale (P<0.001) and 17% on the SRS scale (P=0.017) — with scores drifting back toward baseline after stopping.[2]In type-2 diabetes, a trial of concentrated broccoli-sprout extract reduced fasting glucose and HbA1c in obese patients with poorly-controlled diabetes, working through that same Nrf2 pathway in the liver.[1] These are genuine, peer-reviewed human results — in specific conditions.

The bioavailability problem

Sulforaphane is also unusually tricky to actually absorb. It’s released from a precursor (glucoraphanin) by an enzyme called myrosinase — and when that enzyme is active (as in fresh sprouts), sulforaphane is 3–4 times more bioavailable than from precursor delivered without it.[4] The practical problem: many “sulforaphane” supplements actually contain the stable precursor, not active sulforaphane, so what you absorb depends heavily on the preparation and its delivery.[3] A product’s label number can badly overstate what reaches your cells.

Sulforaphane has real human RCTs — in autism and diabetes. Its longevity and anti-aging claims remain preclinical.
ClaimWhat the evidence supports
Activates Nrf2 / antioxidant defensesYes — well-established mechanism
Improves autism behaviorYes — a randomized trial (niche)
Lowers blood glucose (T2D)Yes — a randomized trial (niche)
Anti-aging / longevity / healthspanPreclinical only — no human outcome data
Reliably absorbed from supplementsDepends on myrosinase / preparation
Sulforaphane has real human RCTs — in autism and diabetes. Its longevity and anti-aging claims remain preclinical. Singh 2014 (PMID 25313065); Axelsson 2017 (PMID 28615356); Fahey 2015 (PMID 26524341)

Safety

As a long-eaten food compound, sulforaphane is of recognized low toxicity and generally well tolerated; concentrated supplement preparations can cause mild GI upset.[2] So the question with sulforaphane, as with most of this category, is efficacy for your goal, not safety.

The honest bottom line

Sulforaphane is a real Nrf2 activator with real randomized human data — just in autism and diabetes, not in aging.[1][2] Its longevity reputation is built on mechanism and animal work, and a chunk of supplement products don’t even deliver the active molecule well. If you eat broccoli sprouts for general health, that’s sensible and safe; if you take a sulforaphane capsule expecting a proven anti-aging effect, the human evidence for that specific claim isn’t there yet. Compare it with other longevity compounds in our longevity evidence matrix, and see GlyNAC and quercetin for the same honest treatment.

Reviewed against primary sources by the Aminoscope desk

Sources

  1. [1] Axelsson AS, Tubbs E, Mecham B, et al. (2017). Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes. Sci Transl Med. PMID 28615356
  2. [2] Singh K, Connors SL, Macklin EA, et al. (2014). Sulforaphane treatment of autism spectrum disorder (ASD). Proc Natl Acad Sci U S A. PMID 25313065
  3. [3] Fahey JW, Wade KL, Wehage SL, et al. (2017). Stabilized sulforaphane for clinical use: Phytochemical delivery efficiency. Mol Nutr Food Res. PMID 27935214
  4. [4] Fahey JW, Holtzclaw WD, Wehage SL, et al. (2015). Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli: Control by Active Endogenous Myrosinase. PLoS One. PMID 26524341

More in Longevity